ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

Simona Toscano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.